|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> 保幼激素 III>> 市场分析报告 |
保幼激素 III市场分析报告 |
|
Global Market Report of JUVENILE HORMONE III (CAS 24198-95-6) December 2024 Global Juvenile Hormone Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect ... 2017 to 2027 is primarily split into: Juvenile Hormone 0 Juvenile Hormone I Juvenile Hormone II Juvenile Hormone III Others In Chapter 6 and Chapter 7.4, based ... Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2020 ... which a pancreas stops producing insulin, a hormone that enables people to get ... therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and features dormant ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, Preclinical, ... Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2020 ... which a pancreas stops producing insulin, a hormone that enables people to get ... therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and features dormant ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, Preclinical, ... Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorder) - Drugs in Development, 2021 ... which a pancreas stops producing insulin, a hormone that enables people to get ... therapeutic development for Type 1 Diabetes (Juvenile Diabetes) and features dormant and ... Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/ ... Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update ... a pancreas stops producing insulin, a hormone that enables people to get ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Phase 0, IND/ ... 34 and 5 molecules, respectively. Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline guide ... Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019 ... Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily ... molecules developed by companies in Phase III, Phase II, Phase I and Preclinical ... , Idiopathic Pulmonary Fibrosis, Inflammation, Juvenile Macular Degeneration (Stargardt Disease ... Pediatric Drugs and Vaccines: Market Research Report This report analyzes the worldwide markets for Pediatric Drugs and Vaccines in US$ Million by the following Therapeutic Class: Pediatric Vaccines, Pediatric Hormones, Allergy & Respiratory Drugs, Anti-infective Drugs, CNS Drugs, and Other Pediatric Drugs. ... T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H1 2018 ... by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and ... Urinary System And Sex Hormones, Metabolic Disorders, Ophthalmology and ... Gravis, Nephrotic Syndrome, Polyarticular Juvenile Idiopathic Arthritis (PJIA), Polymyositis/ ... T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 ... molecules developed by companies in Phase III, Phase I, Preclinical and Discovery ... Urinary System And Sex Hormones, Hematological Disorders, Metabolic Disorders, ... Gravis, Nephrotic Syndrome, Polyarticular Juvenile Idiopathic Arthritis (PJIA), Polymyalgia ... Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update ... type I receptors such as growth hormone, prolactin, leptin, erythropoietin, thrombopoietin ... Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and ... (Scleroderma), Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), ... Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 ... companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical ... Genetic Disorders, Hematological Disorders, Hormonal Disorders, Metabolic Disorders, ... Cancer, Idiopathic Pulmonary Fibrosis, Juvenile Arthritis, Keratoconjunctivitis Sicca (Dry ... Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update ... (Marketed), Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery ... Urinary System And Sex Hormones, Ophthalmology and Women's Health ... , Pancreatic Ductal Adenocarcinoma, Polyarticular Juvenile Idiopathic Arthritis (PJIA), Polycythemia ... T Lymphocyte Activation Antigen CD86 (Activation B7-2 Antigen or CTLA 4 Counter Receptor B7.2 or CD86) - Pipeline Review, H1 2018 ... by companies in Pre-Registration, Phase III, Phase I and Preclinical stages ... Urinary System And Sex Hormones, Oncology, Ophthalmology and Respiratory ... Myasthenia Gravis, Nephrotic Syndrome, Polyarticular Juvenile Idiopathic Arthritis (PJIA), Polymyositis/ ... C-X-C Chemokine Receptor Type 1 - Pipeline Review, H2 2019 ... molecules developed by companies in Phase III, Phase II, Phase I and Preclinical ... ), Colorectal Cancer, Hepatocellular Carcinoma, Hormone Refractory (Castration Resistant, Androgen- ... Cancer (TNBC), Type 1 Diabetes (Juvenile Diabetes) and Uveal Melanoma. ... Tyrosine Protein Kinase JAK2 - Pipeline Review, H1 2020 ... type I receptors such as growth hormone, prolactin, leptin, erythropoietin, thrombopoietin or ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA ... Sclerosis (Scleroderma), Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), ... Tyrosine Protein Kinase JAK2 - Pipeline Review, H2 2020 ... type I receptors such as growth hormone, prolactin, leptin, erythropoietin, thrombopoietin or ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA ... Sclerosis (Scleroderma), Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), ... Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Drugs in Development, 2021 ... type I receptors such as growth hormone, prolactin, leptin, erythropoietin, thrombopoietin ... , Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and ... Sclerosis (Scleroderma), Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease), ... C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018 ... molecules developed by companies in Phase III, Phase II, Preclinical and ... Cell Carcinoma, Hepatocellular Carcinoma, Hormone Refractory (Castration Resistant, Androgen ... Pulmonary Inflammation, Type 1 Diabetes (Juvenile Diabetes) and Unspecified Influenza ... C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2018 ... molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and ... Obstructive Pulmonary Disease (COPD), Hormone Refractory (Castration Resistant, Androgen- ... , Solid Tumor, Type 1 Diabetes (Juvenile Diabetes) and Unspecified Influenza ... |